Evolent Health, Inc. (EVH)
NYSE · Professional Services · Services-Management Services
- Price
- $3.52
- Day
- -2.76%
- Market cap
- $397.97M
Close 2026-09-24.
The company
Our Business Our History Evolent was founded in 2011 by members of our management team, UPMC, an integrated delivery system in Pittsburgh, Pennsylvania, and The Advisory Board Company, to enable providers to pursue a value-based business model and evolve their competitive position and market opportunity. Since that time, we have grown both organically and through acquisitions. Our acquisitions have been focused on companies with extensive experience assisting customers in managing the large and complex specialties of oncology, cardiology, radiology, musculoskeletal, physical medicine, and genetics care. We have one operating segment and one reportable segment as our chief operating decision maker (“CODM”), who is our Chief Executive Officer, assesses the performance of our operations, develops strategy and reviews financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources.
From Item 1: Our Business · Our History.
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- CADIAN CAPITAL MANAGEMENT, LP — $58.61M
- MORGAN STANLEY — $43.93M
- UBS Group AG — $33.78M
- Rubicon Founders LLC — $31.52M
- Engaged Capital LLC — $30.16M
- BlackRock, Inc. — $29.83M
- VANGUARD CAPITAL MANAGEMENT LLC — $25.95M
- BlackRock, Inc. — $24.47M
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- McCarthy Daniel Joseph (PRESIDENT) sold 65,892 shares at $5.00 on 2026-08-26
- Springstubb Brendan B (Director) bought 10,000 shares at $3.82 on 2025-11-18
- Jelinek Richard M (Director) bought 15,000 shares at $9.09 on 2025-03-07
- Jelinek Richard M (Director) bought 15,000 shares at $9.16 on 2025-03-07
- Springstubb Brendan B (Director) bought 15,000 shares at $9.27 on 2025-03-07
- KECK KIM (Director) bought 10,540 shares at $9.44 on 2025-03-07
Recent filings
- SCHEDULE 13G/A — 2026-09-08
- 4 — 2026-08-28
- 144 — 2026-08-26
- 10-Q — 2026-08-06
- 8-K — 2026-08-06
- SCHEDULE 13G — 2026-07-17
- 4 — 2026-07-06
- 4 — 2026-07-06
- 4 — 2026-07-06
- 4 — 2026-07-06